Table 2 MUC5B concentration and inflammatory biomarkers in BALF of NSCAP patients and SCAP patients
From: Respiratory MUC5B disproportion is involved in severe community-acquired pneumonia
| Â | NSCAP | SCAP | p value |
|---|---|---|---|
Muncins in BALF | |||
MUC5B concentration (µg/ml) | 13.56 (5.92–25.79) | 8.20 (4.97–14.03) | 0.011 |
Total protein contentration (mg/ml) | 0.38 (0.15–1.10) | 0.68 (0.46–1.69) | 0.002 |
MUC5B/Total protein percent (%) | 3.66 (1.50–5.56) | 1.38 (0.73–1.76) | < 0.001 |
Inflammatory biomarkers in BALF | |||
IL6 (pg/ml) | 1.81 (1.22–3.08) | 5.83 (2.50–15.73) | < 0.001 |
IL10 (pg/ml) | 0.18 (0.11–0.32) | 0.15 (0.12–0.27) | 0.632 |
IFNγ (pg/ml) | 2.98 (1.90–4.04) | 3.27 (2.11–4.69) | 0.195 |
IL13 (pg/ml) | 30.00 (28.78–31.66) | 31.08 (30.20–33.35) | 0.004 |
IL17 (pg/ml) | 9.53 (6.52–11.23) | 12.04 (9.47–17.54) | < 0.001 |